Table 2.

Effect of SVPII on M-NFS-60 cell cycle progression (24 h; % of total cells)

Group	G0-G1	G2-M	S
24 h Control	40.02 ± 5.25*	2.68 ± 4.58	56.76 ± 1.09*
Serum-free control	57.17 ± 1.66	2.67 ± 3.73	39.88 ± 1.95
SVPII 3 mg/L	39.92 ± 2.15*	2.17 ± 3.45	57.98 ± 5.68*
IL-3 10 μg/L	45.41 ± 3.63*	1.14 ± 1.67	53.13 ± 5.01*

The 24 h control cells were incubated in media containing 10% FCS + 62 μg/L rhM-CSF. All other cultures were treated with media plus rhM-CSF but without serum (serum-free media) or incubated in this same media supplemented with SVPII or IL-3 for 24 h. * P < 0.05 vs. serum-free control.